Fig 1A from Kobak et al 2025, showing words that have increased in use in biomedical abstracts in the last few years and thus may be indicators of LLM use
Zoomed in part of the previous figure, highlighting "steatotic", which does not seem like it would naturally come up much in LLM output, which may instead be due to the new disease nomenclature from 2023.
You know your disease rebrand has been successful when the key term sees as much of an uptick in use as tell-tale words from LLM content (see alt text): www.science.org/doi/10.1126/...
04.09.2025 10:37 β π 1 π 0 π¬ 0 π 0
Science research gets more engagement on Bluesky than X, study finds
Bluesky posts referencing scholarly articles βfind substantially higher levels of interactionβ than on Elon Muskβs platform
NEW: Bluesky is becoming place to discuss scientific research - it gets more proper engagement & attention, new study finds.
For all the talk of decline - borne out by several metrics - the science community seems to have adopted Bluesky more than others.
Story: www.theguardian.com/technology/2...
01.09.2025 10:59 β π 139 π 52 π¬ 6 π 14
Text reads: βDeaths from viral hepatitis-related causes are increasing.
2019: 1.1 million deaths
2022: 1.3 million death
Today is World #Hepatitis Day.
Did you knowβ Hepatitis is the second leading infectious cause of death globally, with hepatitis B and C claiming 3 500 lives every day.
Learn how to protect yourself and your loved ones π bit.ly/hepatitis2025
28.07.2025 07:23 β π 115 π 52 π¬ 0 π 1
πCPG in pressβ
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Find it hereπhttps://bit.ly/4deZHf1
#LiverSky
@easlnews.bsky.social
10.05.2025 06:05 β π 3 π 3 π¬ 1 π 0
NEW PAPER: Updated CONSORT-2025 for reporting randomised trials is now available in the @bmj.com @jama.com , @thelancet.bsky.social, @plos.org and @naturemedicine.bsky.social
β> www.bmj.com/content/389/...
#openscience #transparency #medsky #statssky #episky
15.04.2025 05:55 β π 56 π 40 π¬ 2 π 3
A pie chart with three segments. The largest segment, over half the chart, is labelled "authors who have not ventured an opinion". The next largest, about a third of the chart, is labelled "authors who have stated they opposed lie charts". The smallest segment, about one-eighth of the chart, is labelled "authors who are well aware that other actors dislike pie charts, but committed pie chart crimes anyway." The composer of this alt text notes that if pie charts habitually came with alt text they would be *marginally* less opposed to them.
Members of the ACCORD group are debating data visualisation options for their upcoming @ismpp.bsky.social poster.
03.04.2025 09:29 β π 4 π 5 π¬ 0 π 0
Clinical Trials Information System designated as WHO primary registry | European Medicines Agency (EMA)
Designation facilitates data sharing, promotes transparency and trust in clinical research
The Clinical Trials Information System #CTIS has been designated as primary registry by the @who.int !
This designation represents a significant step forward in promoting transparency and trust in clinical research in the EU.
#clinicaltrials #clinicalresearch www.ema.europa.eu/en/news/clin...
03.04.2025 08:03 β π 45 π 12 π¬ 0 π 1
Really Rapid Review: CROI 2025 San Francisco
Wow, that was an interesting conference β in ways both good and bad. The good part was the content, as the Conference on Retroviruses and Opportunistic Infections (CROI) is our leading HIV research co...
Anyone who attended this year's #CROI2025 will tell you it was a very strange experience given the current political climate. Still, plenty of interesting studies -- here's a Really Rapid Review of selected highlights. #IDSky #HIVSky blogs.jwatch.org/hiv-id-obser...
22.03.2025 10:55 β π 70 π 18 π¬ 7 π 3
Two new cases of HIV remission after stem cell transplant for cancer reported at #CROI2025. These have become so routine that they're posters instead of oral presentations. We know an HIV cure is possible -- now we need to use clues from these rare cases to develop widely applicable approaches.
10.03.2025 21:19 β π 38 π 15 π¬ 2 π 1
Yes, of course. I meant my comment very narrowly, with reference to the outage over the weekend, which does now seem to have been resolved. But agree that in the medium-to-long term the politics could make that sort of technical failure more common.
03.03.2025 12:45 β π 1 π 0 π¬ 0 π 0
Current PubMed issues appear to be (fingers crossed) more technical than political, but good to remind yourself of the alternatives.
02.03.2025 09:36 β π 2 π 0 π¬ 1 π 0
This afternoon! Or this morning for those in the US. Or this evening for those in AP, I guess. Either way: not many hours from now.
27.02.2025 12:58 β π 3 π 0 π¬ 0 π 0
Read our editorial on the need for communication and collaboration when developing reporting guidelines @equatornetwork.bsky.social
19.02.2025 14:50 β π 5 π 5 π¬ 0 π 0
Always powerful to see the graph showing the impact of PEPFAR blogs.jwatch.org/hiv-id-obser...
06.02.2025 17:17 β π 0 π 0 π¬ 0 π 0
What's Happening Inside the NIH and NSF
A long post about whatβs happening to the science funding agencies in the US and why. As mentioned, this one just kept getting longer even as I kept stripping curse words from it.
www.science.org/content/blog...
04.02.2025 16:40 β π 415 π 292 π¬ 20 π 42
Fascinating comment in passing there about ASCO having been spammed with AI submissions -- does anyone know anything more about that? #ISMPPeurope
29.01.2025 15:43 β π 2 π 0 π¬ 0 π 0
(Someone has just made this point! A balloon debate on publication tools might be interesting next year... #ISMPPeurope)
29.01.2025 10:33 β π 1 π 0 π¬ 0 π 0
I do think AI was a little short-changed, on the grounds that it's a tool not a format, so it's not quite a fair comparison #ISMPPeurope
29.01.2025 10:32 β π 1 π 0 π¬ 1 π 0
An occasional issue with the day 2 repeated-plenary format is that if the plenary leans on presentation or panel discussion, round 2 can be a bit stale. This format turns the structure - the fact that the audience is what changes - into a strength. #ISMPPeurope
29.01.2025 10:31 β π 0 π 0 π¬ 2 π 0
The balloon debate on publication formats made for an interesting session, and clever choice of format #ISMPPeurope
29.01.2025 10:30 β π 0 π 0 π¬ 1 π 0
Enjoying the "maintaining quality in a fast-paced world" session. I think I might actually quite enjoy a 48-hour "all the authors in a room writing the draft" challenge... #ISMPPeurope
28.01.2025 14:00 β π 1 π 0 π¬ 1 π 0
Important update: found a stand offering Venchi. I approve even more. #ISMPPeurope
28.01.2025 13:30 β π 0 π 0 π¬ 0 π 0
Key takeaway from the exhibition: lindor are the giveaway of choice. I approve. #ISMPPeurope
28.01.2025 13:14 β π 0 π 0 π¬ 0 π 1
Picture of a food label that says "garlic lemon boneless chicken tights with roosted sweet potatoes"; presumably meant to be chicken thighs and roasted sweet potatoes
The lunch labels may have needed a proofread! #ISMPPeurope
28.01.2025 12:21 β π 4 π 0 π¬ 1 π 0
In mice is on Bluesky as well! #ISMPPeurope
28.01.2025 11:26 β π 1 π 0 π¬ 0 π 0
A photo of a plenary meeting room full of people, listening to Rob Matheis deliver the Chair's Welcome at the ISMPP EU 2025 meeting
The @ismpp.bsky.social EU meeting is underway! #ismppeu2025
28.01.2025 10:38 β π 2 π 0 π¬ 0 π 0
Clinical Trial Readouts Are A-Comin'
Some clinical trial results to look forward to this year:
22.01.2025 21:19 β π 28 π 8 π¬ 2 π 0
Artificial intelligence is infiltrating health care. We shouldnβt let it make all the decisions.
AI paternalism could put patient autonomy at riskβif we let it.
Interesting piece in @mitpress.bsky.social Tech Review about #AI paternalism in healthcare. i.e. "the doctor knows best" being replaced by AI knows best, both dismissing patient experience: www.technologyreview.com/2023/04/21/1...
08.01.2025 11:59 β π 4 π 4 π¬ 0 π 1
Ah yes, that early January "suddenly it's only three weeks to @ismpp.bsky.social why didn't I do more prep in December" feeling
06.01.2025 16:09 β π 1 π 0 π¬ 0 π 0
Now you have to make a medcomms starter pack!
07.12.2024 08:50 β π 1 π 0 π¬ 0 π 0
Peer-reviewed academic journal on research integrity and ethics.
An interdisciplinary forum across sciences, medicine, law, management, public policy, and history.
βοΈ @gengyantang.bsky.social
Writer, editor, #healthpolicy nerd. Loves evidence, humans, the NHS, equity. NUJ. Green. Grew up on free school meals.
Surprisingly good at identifying plants. Stroud-based. π§caroline.molloy@cantab.net
Co-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Open Philanthropy. // Previously at Our World in Data.
Newsletter: https://scientificdiscovery.dev
Podcast: https://harddrugs.worksinprogress.co
π³οΈβπ
Biomedical research communication, publishing, tech, open research, open data, meta research, peer review. Executive Editor, @bmj.com Co-Founder @medrxivpreprint.bsky.social.
We make finding and interpreting global research data fast and simple.
Europe PMC provides comprehensive access to life sciences literature from trusted sources. It's available to anyone, anywhere for free. https://europepmc.org/
Chief Science and Strategy Officer, openRxiv. Co-Founder, bioRxiv and medRxiv.
Director of Innovation at Oxford PharmaGenesis. Professional account for all things science communication, AI and open access. Opinions expressed are my own.
Welcome to the official Bluesky account for the New England Journal of Medicine!
Follow us for high-quality, peer-reviewed research and clinical content from the worldβs leading medical journal and website (NEJM.org).
We (The World Health Organization) are the United Nationsβ health agency championing Health For All. Always check the latest posts for updated advice/information. We will remove misinformation, spam, and hate speech here.
Let's unite Hepatology! Become a member today and discover your membership benefits.
____________
RT β endorsement. We express no political views.
Fighting for a world free from #hepatitis #by2030. Follow to help eliminate this deadly disease, which claims one life every 30 seconds. worldhepatitisalliance.org
EU regulatory authority working for public and animal health.
We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam.
https://www.ema.europa.eu/
The Lancet Regional Health-Europe publishes #OpenAccess research that advocates change in clinical practice & health policy in Europe.
π https://www.thelancet.com/journals/lanepe/home
Connecting voices from the #WesternPacific to the global community with high-quality #OpenAccess research that impacts clinical practice & health policy.
π https://www.thelancet.com/journals/lanwpc/home
An interdisciplinary #OpenAccess journal publishing research, review and comment on #Planetaryhealth #Environment, #SustainableDevelopment, and #SDGs.
π thelancet.com/journals/lanplh/home
We are a grant-making organisation dedicated exclusively to ending viral hepatitis.
The Lancet Gastroenterology & Hepatology is the world-leading #gastroenterology and #hepatology research journal. IF=38.6.
π thelancet.com/journals/langas/home